Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salvati, V M
Right arrow Articles by Troncone, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salvati, V M
Right arrow Articles by Troncone, R
Gut 2005;54:46-53
© 2005 by BMJ Publishing Group Ltd & British Society of Gastroenterology


COELIAC DISEASE

Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa

V M Salvati1, G Mazzarella2, C Gianfrani2, M K Levings3,*, R Stefanile2, B De Giulio2, G Iaquinto4, N Giardullo4, S Auricchio1, M G Roncarolo3, R Troncone1

1 Department of Paediatrics and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
2 Institute of Food, Science, and Technology, CNR Avellino, Italy
3 San Raffaele Telethon Institute of Gene Therapy (HSR-TIGET), San Raffaele Scientific Institute, Milan, Italy
4 Gastroenterology and Endoscopy Unit Hospital, "San Giuseppe Moscati", Avellino, Italy

Correspondence to:
Correspondence to:
Professor R Troncone
Department of Paediatrics, University Federico II, Via Pansini, No 5, 80131 Naples, Italy; troncone{at}unina.it

Background: Enteropathy in coeliac disease (CD) is sustained by a gliadin specific Th1 response. Interleukin (IL)-10 can downregulate Th1 immune responses.

Aim: We investigated the ability of recombinant human (rh) IL-10 to suppress gliadin induced Th1 response.

Patients and methods: IL-10 RNA transcripts were analysed by competitive reverse transcription-polymerase chain reaction in duodenal biopsies from untreated and treated CD patients, non-coeliac enteropathies (NCE), and controls. CD biopsies were cultured with a peptic-tryptic digest of gliadin with or without rhIL-10. The proportion of CD80+ and CD25+ cells in the lamina propria, epithelial expression of Fas, intraepithelial infiltration of CD3+ cells, as well as cytokine synthesis (interferon {gamma} (IFN-{gamma}) and IL-2) were measured. Short term T cell lines (TCLs) obtained from treated CD biopsies cultured with gliadin with or without rhIL-10 were analysed by ELISPOT for gliadin specific production of IFN-{gamma}.

Results: In untreated CD and NCE, IL-10 RNA transcripts were significantly upregulated. In ex vivo organ cultures, rhIL-10 downregulated gliadin induced cytokine synthesis, inhibited intraepithelial migration of CD3+ cells, and reduced the proportion of lamina propria CD25+ and CD80+ cells whereas it did not interfere with epithelial Fas expression. In short term TCLs, rhIL-10 abrogated the IFN-{gamma} response to gliadin.

Conclusions: rhIL-10 suppresses gliadin specific T cell activation. It may interfere with the antigen presenting capacity of lamina propria mononuclear cells as it reduces the expression of CD80. Interestingly, rhIL-10 also induces a long term hyporesponsiveness of gliadin specific mucosal T cells. These results offer new perspectives for therapeutic strategies in coeliac patients based on immune modulation by IL-10.


Abbreviations: CD, coeliac disease; IL-10, interleukin 10; rhIL-10, human recombinant IL-10; NCE, non-coeliac enteropathy; RT-PCR, reverse transcription-polymerase chain reaction; TCL, T cell lines; IFN-{gamma}, interferon {gamma}; Tr1 cells, type 1 T regulatory cells; TGF-ß, transforming growth factor ß; LPT, lamina propria T cells; IELs, intraepithelial lymphocytes; PT, peptic-tryptic; mAb, monoclonal antibody; PBS, phosphate buffered saline; tTG, tissue transglutaminase; PBMCs, peripheral blood mononuclear cells; SFC, spot forming cells

Keywords: interleukin 10; coeliac disease; immune suppression; organ culture; gliadin specific T cell lines




This article has been cited by other articles:


Home page
Clin. Chem.Home page
M. Papp, I. Foldi, E. Nemes, M. Udvardy, J. Harsfalvi, I. Altorjay, I. Mate, T. Dinya, C. Varvolgyi, Z. Barta, et al.
Haptoglobin Polymorphism: A Novel Genetic Risk Factor for Celiac Disease Development and Its Clinical Manifestations
Clin. Chem., April 1, 2008; 54(4): 697 - 704.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Silano, R. Di Benedetto, F. Maialetti, A. De Vincenzi, R. Calcaterra, A. Trecca, and M. De Vincenzi
A 10-residue peptide from durum wheat promotes a shift from a Th1-type response toward a Th2-type response in celiac disease
Am. J. Clinical Nutrition, February 1, 2008; 87(2): 415 - 423.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. Forsberg, O. Hernell, S. Hammarstrom, and M.-L. Hammarstrom
Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease
Int. Immunol., August 1, 2007; 19(8): 993 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
C. G. Rizzello, M. De Angelis, R. Di Cagno, A. Camarca, M. Silano, I. Losito, M. De Vincenzi, M. D. De Bari, F. Palmisano, F. Maurano, et al.
Highly Efficient Gluten Degradation by Lactobacilli and Fungal Proteases during Food Processing: New Perspectives for Celiac Disease
Appl. Envir. Microbiol., July 15, 2007; 73(14): 4499 - 4507.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Gianfrani, M. K. Levings, C. Sartirana, G. Mazzarella, G. Barba, D. Zanzi, A. Camarca, G. Iaquinto, N. Giardullo, S. Auricchio, et al.
Gliadin-Specific Type 1 Regulatory T Cells from the Intestinal Mucosa of Treated Celiac Patients Inhibit Pathogenic T Cells
J. Immunol., September 15, 2006; 177(6): 4178 - 4186.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology